IL-33-ILC2 axis promotes anti-tumor CD8+ T cell responses via OX40 signaling
Yuko Okuyama, Akira Okajima, Nao Sakamoto, Ayaka Hashimoto, Ryuto Tanabe, Akihisa Kawajiri, Takeshi Kawabe, Naoto Ishii
Topics & Concepts
CD8Innate lymphoid cellCytotoxic T cellTumor microenvironmentBiologyCancer researchInterleukin 33T cellImmunologyAcquired immune systemChemistryCell biologyImmune systemInterleukinCytokineIn vitroBiochemistryIL-33, ST2, and ILC PathwaysImmune Cell Function and InteractionEosinophilic Esophagitis